CIK 0001576280
- Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454139254
- Phone
- +1 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,720,952
- in 8 filings, $195K under 10b5-1 plans
Net −$9,720,952. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Freeman Chris Chief Commercial Officer | Option exercise | +1,929 | 67,303 | ||
| 2026-10-01 | Freeman Chris Chief Commercial Officer | Option exercise | +1,668 | 68,971 | ||
| 2026-10-01 | Freeman Chris Chief Commercial Officer | Option exercise | +2,527 | 71,498 | ||
| 2026-10-01 | Freeman Chris Chief Commercial Officer | Option exercise | +1,292 | 72,790 | ||
| 2026-10-01 | Freeman Chris Chief Commercial Officer | Shares withheld for taxes | −3,143 | $174.75 | $549K | 69,647 |
| 2026-10-01 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,929 | 0 | ||
| 2026-10-01 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,668 | 0 | ||
| 2026-10-01 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −2,527 | 10,105 | ||
| 2026-10-01 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,292 | 7,754 | ||
| 2026-08-10 | Freeman Chris Chief Commercial Officer | Option exercise | +35,412 | $110.49 | $3.9M | 100,786 |
| 2026-08-10 | Freeman Chris Chief Commercial Officer | Option exercise | +28,193 | $28.37 | $800K | 128,979 |
| 2026-08-10 | Freeman Chris Chief Commercial Officer | Sale | −3,463 | $167.38 | $580K | 125,516 |
| 2026-08-10 | Freeman Chris Chief Commercial Officer | Sale | −7,365 | $168.79 | $1.2M | 118,151 |
| 2026-08-10 | Freeman Chris Chief Commercial Officer | Sale | −35,364 | $169.63 | $6.0M | 82,787 |
| 2026-08-10 | Freeman Chris Chief Commercial Officer | Sale | −17,413 | $170.24 | $3.0M | 65,374 |
| 2026-08-10 | Freeman Chris Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) | −35,412 | 3,620 | ||
| 2026-08-10 | Freeman Chris Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) | −28,193 | 1,668 | ||
| 2026-07-01 | Freeman Chris Chief Commercial Officer | Option exercise | +1,928 | 63,029 | ||
| 2026-07-01 | Freeman Chris Chief Commercial Officer | Option exercise | +1,667 | 64,696 | ||
| 2026-07-01 | Freeman Chris Chief Commercial Officer | Option exercise | +2,526 | 67,222 |
Page 1 of 5 · 82 trades